Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Lantheus Holdings, Inc. due to misleading statements regarding the competitive position of its product Pylarify, which led to inflated stock prices and subsequent losses for investors [1][3]. Company Overview - Lantheus Holdings, Inc. (NASDAQ: LNTH) is facing a federal securities class action with a deadline for lead plaintiff applications set for November 10, 2025 [1][6]. - The company has experienced significant stock price volatility, particularly following disappointing financial results related to Pylarify [4][5]. Financial Performance - Lantheus reported first-quarter results below market expectations on May 7, 2025, with Pylarify's performance notably underwhelming [4]. - On August 6, 2025, the company announced further disappointing results, revealing an 8.3% year-over-year decline in Pylarify's performance and a reduction in fiscal year 2025 growth projections [4]. Stock Market Reaction - Following the negative announcements, Lantheus' stock price plummeted from $72.83 per share on August 5, 2025, to $51.87 per share on August 6, 2025, marking a decline of approximately 28.8% in one day [5]. Legal Proceedings - The lead plaintiff in the class action will be the investor with the largest financial interest who can adequately represent the class [6]. - Faruqi & Faruqi encourages individuals with information regarding Lantheus' conduct to come forward, including whistleblowers and former employees [6].
LNTH SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus